{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:47:29Z","timestamp":1785797249389,"version":"3.56.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1177\/1933719114525266","type":"journal-article","created":{"date-parts":[[2014,2,27]],"date-time":"2014-02-27T01:46:57Z","timestamp":1393465617000},"page":"1153-1160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Antitumor Effects of Flavopiridol on Human Uterine Leiomyoma In Vitro and in a Xenograft Model"],"prefix":"10.1007","volume":"21","author":[{"given":"Hyun-Gyo","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Woo","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Jin","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hoon","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon-Do","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Som","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gun-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Heum","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,30]]},"reference":[{"issue":"6","key":"21091153_CR1","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.fertnstert.2006.11.093","volume":"87","author":"WH Catherino","year":"2007","unstructured":"Catherino WH, Malik M. Uterine leiomyoma express a molecular pattern that lowers retinoic acid exposure. Fertil Steril. 2007; 87(6):1388\u20131398.","journal-title":"Fertil Steril"},{"issue":"1","key":"21091153_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/07435807509053836","volume":"2","author":"A Corbin","year":"1975","unstructured":"Corbin A, Beattie CW. Inhibition of the pre-ovulatory proestrous gonadotropin surge, ovulation and pregnancy with a peptide analogue of luteinizing hormone releasing hormone. Endocr Res Commun. 1975;2(1):1\u201323.","journal-title":"Endocr Res Commun"},{"issue":"5","key":"21091153_CR3","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/j.1471-0528.2004.00504.x","volume":"112","author":"PA Flierman","year":"2005","unstructured":"Flierman PA, Oberye JJ, Van der Hulst VP, de Blok S. Rapid reduction of leiomyoma volume during treatment with the GnRH antagonist ganirelix. BJOG. 2005;112(5):638\u2013642.","journal-title":"BJOG"},{"issue":"5","key":"21091153_CR4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1056\/NEJMoa1103180","volume":"366","author":"J Donnez","year":"2012","unstructured":"Donnez J, Tomaszewski J, Vazquez F, et al. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med. 2012; 366(5):421\u2013432.","journal-title":"N Engl J Med"},{"issue":"7","key":"21091153_CR5","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1158\/1535-7163.873.3.7","volume":"3","author":"S Grant","year":"2004","unstructured":"Grant S, Dent P. Gene profiling and the cyclin-dependent kinase inhibitor flavopiridol: what\u2019s in a name? Mol Cancer Ther. 2004; 3(7):873\u2013875.","journal-title":"Mol Cancer Ther"},{"issue":"7","key":"21091153_CR6","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1182\/blood-2005-04-1678","volume":"106","author":"R Chen","year":"2005","unstructured":"Chen R, Keating MJ, Gandhi V, Plunkett W. Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell death. Blood. 2005;106(7):2513\u20132519.","journal-title":"Blood"},{"issue":"3","key":"21091153_CR7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.4161\/cc.2.3.357","volume":"2","author":"EW Newcomb","year":"2003","unstructured":"Newcomb EW, Tamasdan C, Entzminger Y, et al. Flavopiridol induces mitochondrial-mediated apoptosis in murine glioma GL261 cells via release of cytochrome c and apoptosis inducing factor. Cell Cycle. 2003;2(3):243\u2013250.","journal-title":"Cell Cycle"},{"issue":"7","key":"21091153_CR8","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3324\/haematol.2008.004861","volume":"94","author":"P Bonvini","year":"2009","unstructured":"Bonvini P, Zorzi E, Mussolin L, et al. The effect of the cyclin-dependent kinase inhibitor flavopiridol on anaplastic large cell lymphoma cells and relationship with NPM-ALK kinase expression and activity. Haematologica. 2009;94(7):944\u2013955.","journal-title":"Haematologica"},{"issue":"3","key":"21091153_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1023\/A:1006353008903","volume":"17","author":"AM Senderowicz","year":"1999","unstructured":"Senderowicz AM. Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials. Invest New Drugs. 1999;17(3): 313\u2013320.","journal-title":"Invest New Drugs"},{"issue":"12","key":"21091153_CR10","doi-asserted-by":"publisher","first-page":"6380","DOI":"10.1073\/pnas.94.12.6380","volume":"94","author":"S Fredersdorf","year":"1997","unstructured":"Fredersdorf S, Burns J, Milne AM, et al. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci U S A. 1997;94(12):6380\u20136385.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"21091153_CR11","first-page":"3381","volume":"57","author":"V Esposito","year":"1997","unstructured":"Esposito V, Baldi A, De Luca A, et al. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res. 1997;57(16):3381\u20133385.","journal-title":"Cancer Res"},{"issue":"2","key":"21091153_CR12","first-page":"169","volume":"11","author":"LA Erickson","year":"1998","unstructured":"Erickson LA, Jin L, Wollan PC, Thompson GB, van Heerden J, Lloyd RV. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Mod Pathol. 1998;11(2):169\u2013174.","journal-title":"Mod Pathol"},{"issue":"4","key":"21091153_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3346\/jkms.2008.23.4.667","volume":"23","author":"S Ramachandran","year":"2008","unstructured":"Ramachandran S, Kwon KY, Shin SJ, et al. Cyclin-dependent kinase inhibitor p27kip1 controls growth and cell cycle progression in human uterine leiomyoma. J Korean Medi Sci. 2008;23(4):667\u2013673.","journal-title":"J Korean Medi Sci"},{"issue":"10","key":"21091153_CR14","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1210\/endo.142.10.8455","volume":"142","author":"T Shiozawa","year":"2001","unstructured":"Shiozawa T, Horiuchi A, Kato K, et al. Up-regulation of p27Kip1 by progestins is involved in the growth suppression of the normal and malignant human endometrial glandular cells. Endocrinology. 2001;142(10):4182\u20134188.","journal-title":"Endocrinology"},{"issue":"3","key":"21091153_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10637-005-6728-x","volume":"23","author":"F Mayer","year":"2005","unstructured":"Mayer F, Mueller S, Malenke E, Kuczyk M, Hartmann JT, Boke-meyer C. Induction of apoptosis by flavopiridol unrelated to cell cycle arrest in germ cell tumour derived cell lines. Invest New Drugs. 2005;23(3):205\u2013211.","journal-title":"Invest New Drugs"},{"issue":"13","key":"21091153_CR16","first-page":"2973","volume":"56","author":"BA Carlson","year":"1996","unstructured":"Carlson BA, Dubay MM, Sausville EA, Brizuela L, Worland PJ. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. Cancer Res. 1996;56(13):2973\u20132978.","journal-title":"Cancer Res"},{"issue":"2\u20133","key":"21091153_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0169-5002(00)00195-1","volume":"31","author":"KH Park","year":"2001","unstructured":"Park KH, Seol JY, Yoo CG, et al. Adenovirus expressing p27(Kip1) induces growth arrest of lung cancer cell lines and suppresses the growth of established lung cancer xenografts. Lung Cancer. 2001;31(2\u20133):149\u2013155.","journal-title":"Lung Cancer"},{"issue":"3","key":"21091153_CR18","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.fertnstert.2012.11.032","volume":"99","author":"M Drosch","year":"2013","unstructured":"Drosch M, Bullerdiek J, Zollner TM, Prinz F, Koch M, Schmidt N. A novel mouse model that closely mimics human uterine leiomyomas. Fertil Steril. 2013;99(3):927\u2013935.","journal-title":"Fertil Steril"},{"issue":"3","key":"21091153_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/humupd\/dmh019","volume":"10","author":"T Maruo","year":"2004","unstructured":"Maruo T, Ohara N, Wang J, Matsuo H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Report Update. 2004;10(3):207\u2013220.","journal-title":"Hum Report Update"},{"issue":"9","key":"21091153_CR20","first-page":"493","volume":"16","author":"K Pollw","year":"1978","unstructured":"Pollw K, Sinnecker G, Boquoi E, Pollow B. In vitro conversion of estradiol-17 into estrone in normal human myometrium and leiomyoma. J Clin Chem Clin Biochem. 1978;16(9):493\u2013502.","journal-title":"J Clin Chem Clin Biochem"},{"issue":"2","key":"21091153_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1677\/joe.0.0560341","volume":"56","author":"BF Clark","year":"1973","unstructured":"Clark BF. The effects of oestrogen and progesterone on uterine cell division and epithelial morphology in spayed-hypophysectomized rats. J Endocrinol. 1973;56(2):341\u2013342.","journal-title":"J Endocrinol"},{"issue":"1","key":"21091153_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1530\/jrf.0.0310059","volume":"31","author":"C Tachi","year":"1972","unstructured":"Tachi C, Tachi S, Lindner HR. Modification by progesterone of estradiol induced cell proliferation, RNA synthesis and oestradiol distribution in the rat uterus. J Repord Fertil. 1972;31(1):59\u201376.","journal-title":"J Repord Fertil"},{"issue":"3","key":"21091153_CR23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/35106065","volume":"1","author":"M Malumbres","year":"2001","unstructured":"Malumbres M, Barbacid M. To cycle or not to cycle: a decision in cancer. Nat Rev Cancer. 2001;1(3):222\u2013231.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"21091153_CR24","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s00018-002-8410-1","volume":"59","author":"AJ Obaya","year":"2002","unstructured":"Obaya AJ, Sedivy JM. Regulation of cyclin-cdk activity in mammalian cells. Cell Mol Life Sci. 2002;59(1):126\u2013142.","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"21091153_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4143\/crt.2005.37.3.191","volume":"37","author":"S Kim","year":"2005","unstructured":"Kim S, Wu HG, Shin JH, Park HJ, Kim IA, Kim IH. Enhancement of radiation effect by flavopiridol in uterine cervix cancer cells. Cancer Res Treat. 2005;37(3):191\u2013195.","journal-title":"Cancer Res Treat"},{"issue":"2","key":"21091153_CR26","first-page":"139","volume":"2","author":"M Alonso","year":"2003","unstructured":"Alonso M, Tamasdan C, Miller DC, Newcomb EW. Flavopiridol induces apoptosis in glioma cell lines independent of retinoblatoma and p53 tumor suppressor pathway alterations by a caspase-independent pathway. Mol Cancer Ther. 2003;2(2): 139\u2013150.","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"21091153_CR27","first-page":"571","volume":"11","author":"P Zhou","year":"1995","unstructured":"Zhou P, Jiang W, Zhang YJ, et al. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human oesophageal cancer cells. Oncogene. 1995;11(3):571\u2013580.","journal-title":"Oncogene"},{"issue":"11","key":"21091153_CR28","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1200\/JCO.2005.03.7689","volume":"24","author":"GI Shapiro","year":"2006","unstructured":"Shapiro GI. Cyclin-dependent kinase pathways as targets for cancer treatment. J Clin Oncol. 2006;24(11):1770\u20131783.","journal-title":"J Clin Oncol"},{"issue":"9","key":"21091153_CR29","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1172\/JCI3661","volume":"102","author":"V Patel","year":"1998","unstructured":"Patel V, Senderowicz AM, Pinto D Jr, et al. Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis. J Clin Invest. 1998;102(9):1674\u20131681.","journal-title":"J Clin Invest"},{"issue":"10","key":"21091153_CR30","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1038\/sj.onc.1208375","volume":"24","author":"M Lechpammer","year":"2005","unstructured":"Lechpammer M, Xu X, Ellis FH, Bhattacharaya N, Shapiro GI, Loda M. Flavopiridol reduces malignant transformation of the oesophageal mucosa in p27 knockout mice. Oncogene. 2005; 24(10):1683\u20131688.","journal-title":"Oncogene"},{"issue":"2","key":"21091153_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S1040-8428(00)00124-4","volume":"38","author":"HH Sedlacek","year":"2001","unstructured":"Sedlacek HH. Mechanism of action of flavopiridol. Crit Rev Oncol Hematol. 2001;38(2):139\u2013170.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"31","key":"21091153_CR32","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.1038\/sj.onc.1210243","volume":"26","author":"C Berthet","year":"2007","unstructured":"Berthet C, Kaldis P. Cell-specific responses to loss of cyclin-dependent kinases. Oncogene. 2007;26(31):4469\u20134477.","journal-title":"Oncogene"},{"issue":"2","key":"21091153_CR33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.devcel.2008.01.013","volume":"14","author":"A Besson","year":"2008","unstructured":"Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Dev Cell. 2008;14(2):159\u2013169.","journal-title":"Dev Cell"},{"issue":"12 pt 2","key":"21091153_CR34","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1158\/1078-0432.CCR-040020","volume":"10","author":"GI Shapiro","year":"2004","unstructured":"Shapiro GI. Preclinical and clinical development of the cyclin dependent kinase inhibitor flavopiridol. Clin Cancer Res. 2004; 10(12 pt 2):4270\u20134275.","journal-title":"Clin Cancer Res"},{"issue":"5728","key":"21091153_CR35","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1126\/science.1112063","volume":"308","author":"CL Walker","year":"2005","unstructured":"Walker CL, Stewart EA. Uterine fibroids: the elephant in the room. Science. 2005;308(5728):1589\u20131592.","journal-title":"Science"},{"issue":"11","key":"21091153_CR36","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.1210\/jc.2004-0161","volume":"89","author":"L Ding","year":"2004","unstructured":"Ding L, Xu J, Luo X, Chegini N. Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase\/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasmi-nogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells. J Clin Endocrinol Metab. 2004; 89(11):5549\u20135557.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"21091153_CR37","first-page":"2482","volume":"91","author":"F Arguello","year":"1998","unstructured":"Arguello F, Alexander M, Sterry JA, et al. Flavopiridol induces apoptosis of normal lymphoid cells, causes immuno-suppression, and has potent antitumor activity in vivo against human leukemia and lymphoma xenografts. Blood. 1998; 91(7):2482\u20132490.","journal-title":"Blood"},{"issue":"6B","key":"21091153_CR38","first-page":"4341","volume":"25","author":"A Wirger","year":"2005","unstructured":"Wirger A, Perabo FG, Burgemeister S, et al. Flavopiridol, an inhibitor of cyclin-dependent kinases, induces growth inhibition and apoptosis in bladder cancer cells in vitro and in vivo. Anticancer Res. 2005;25(6B):4341\u20134347.","journal-title":"Anticancer Res"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719114525266.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1933719114525266","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1177\/1933719114525266\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1933719114525266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719114525266.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T01:31:32Z","timestamp":1656811892000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1177\/1933719114525266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["21091153"],"URL":"https:\/\/doi.org\/10.1177\/1933719114525266","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"30 December 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}